Abstract: Embodiments are directed to a series of novel small molecule activators of NRF2 dependent gene expression that are evaluated in an effort to develop therapeutic methods against diseases with deregulated KEAP1-NRF2 signaling.

Abstract: Radioisotope-labeled small molecule activity-based probes that target the cancer associated serine hydrolase neutral cholesterol ester hydrolase 1 (NCEH1) are described. The probes can undergo a reaction with the NCEH1, resulting in covalent bonding of a portion of the probe molecule to the NCEH1. Also described are methods of labeling NCEH1 in biological samples, such as cells or tissue, and methods of visualizing tumors using the radioisotope-labeled NCEH1 probes as tracer compounds, either alone or in combination with assessing the efficacy of a cancer treatment or potential cancer treatment.

Abstract: Embodiments are directed to a series of novel small molecule activators of NRF2 dependent gene expression that are evaluated in an effort to develop therapeutic methods against diseases with deregulated KEAP1-NRF2 signaling.

Abstract: This disclosure provides compounds and compositions which may be modulators of MAGL and/or ABHD6 and their use as medicinal agents, processes for their preparation, and pharmaceutical compositions that include disclosed compounds as at least one active agent. The disclosure also provides for method of treating a patient in need thereof, where the patient is suffering from post-traumatic stress disorder comprising administering a disclosed compound or composition.

Abstract: Provided is an antenna integrated structure in which an antenna is inserted into ground vehicle, marine ship and aircraft structure, and more particularly, a sandwich panel type antenna integrated latticecore having a structure for improving communication performance of an antenna module.

Abstract: The present disclosure provides novel heteroaryl compounds of formula (IX). Such compounds are useful for the treatment of cancers.

Abstract: The present disclosure provides novel heteroaryl compounds of formula (VII). Such compounds are useful for the treatment of cancers.

Abstract: The present invention relates to a conjugated polymer compound for a polymer solar cell donor and a polymer solar cell comprising same, wherein the conjugated polymer compound has a D-A form in which an electron-donating unit (benzodithiophene, BDT) and an electron-withdrawing unit (quinoxline, Qx) are combined, where a cyano (CN) substituent instead of fluorine (F) is introduced into the Qx unit to improve charge generation, charge transfer, and charge recombination characteristics of the polymer solar cell regardless of the type of acceptor contained in a photo-active layer, so that a polymer solar cell with greatly improved photo-conversion efficiency (PCE) can be implemented.

Abstract: This disclosure provides compounds and compositions which may be modulators of MAGL and/or ABHD6 and their use as medicinal agents, processes for their preparation, and pharmaceutical compositions that include disclosed compounds as at least one active agent. The disclosure also provides for method of treating a patient in need thereof, where the patient is suffering from post-traumatic stress disorder comprising administering a disclosed compound or composition.

Abstract: Discussed is a solar cell including a semiconductor substrate, a conductive region disposed in the semiconductor substrate or over the semiconductor substrate, and an electrode electrically connected to the conductive region. The electrode includes a first electrode part and a second electrode part disposed over the first electrode part. The second electrode part includes a particle connection layer formed by connecting a plurality of particles including a first metal and a cover layer including a second metal different from the first metal and covering at least the outside surface of the particle connection layer.

Abstract: Discussed is a solar cell including a semiconductor substrate having an inclined part; first and second conductivity type regions formed at or on one surface of the semiconductor substrate; a first electrode connected to the first conductivity type region on the one surface of the semiconductor substrate; and a second electrode connected to the second conductivity type region on the one surface of the semiconductor substrate. At least one of the first and second electrodes includes a finger part including a plurality of inner finger parts extending in a first direction, and a plurality of outer finger parts extending in the first direction adjacent to an edge of the semiconductor substrate; and a connection part connecting at least some of the plurality of outer finger parts on one side of the semiconductor substrate adjacent to the inclined part.

Abstract: This disclosure provides compounds and compositions which may be modulators of MAGL and/or ABHD6 and their use as medicinal agents, processes for their preparation, and pharmaceutical compositions that include disclosed compounds as at least one active agent. The disclosure also provides for method of treating a patient in need thereof, where the patient is suffering from post-traumatic stress disorder comprising administering a disclosed compound or composition.

Abstract: An all metal wideband tapered slot phase array antenna includes: a ground plate; and a plurality of antennas arranged on the ground plate, wherein each of the antennas includes radiators configured to face each other with respect to a center line, forming an inclined surface that starts from the ground plate and decreases in width in an exponential manner, and having a non-uniform thickness.

Abstract: Provided is a connected gateway server system for real-time vehicle control service that includes a vehicle terminal mounted on at least one vehicle; a gateway server relaying communication with the vehicle terminal; a connected gateway server for controlling a vehicle and acquiring a vehicle information in the form of REST API for each user through communication with the vehicle terminal, delivering a control command, a response information, and the vehicle information to the user's platform that has been validated as an API form, storing a terminal connection state information, an API authentication information, the vehicle information, and a user information, and performing a confirmation of update state and an update request of vehicle terminal; and an user platform for verifying validity in an API token manner through communication with the connected gateway server, fetching a necessary vehicle information in the API form or issuing the control command of vehicle.

Abstract: The present disclosure provides novel heteroaryl compounds of formula (VII). Such compounds are useful for the treatment of cancers.

Abstract: A method of, and a mobile terminal configured for, efficiently displaying an event indication in the form of a pop-up box during idle mode of a mobile terminal is provided. Upon occurrence of a second event in idle mode, it is determined whether an event pop-up box indicating an occurrence of a first event of the same type as the second event exists. When the event pop-up box indicating the occurrence of the first event exists, the event pop-up box is updated with information indicating the occurrence of the second event and displayed on a display.

Abstract: The present disclosure provides novel heteroaryl compounds of formula (IV). Such compounds are useful for the treatment of cancers.

Abstract: Embodiments are directed to a series of novel small molecule activators of NRF2 dependent gene expression that are evaluated in an effort to develop therapeutic methods against diseases with deregulated KEAP1-NRF2 signaling.

Abstract: Radioisotope-labeled small molecule activity-based probes that target the cancer associated serine hydrolase neutral cholesterol ester hydrolase 1 (NCEH1) are described. The probes can undergo a reaction with the NCEH1, resulting in covalent bonding of a portion of the probe molecule to the NCEH1. Also described are methods of labeling NCEH1 in biological samples, such as cells or tissue, and methods of visualizing tumors using the radioisotope-labeled NCEH1 probes as tracer compounds, either alone or in combination with assessing the efficacy of a cancer treatment or potential cancer treatment.

Abstract: This disclosure provides compounds and compositions which may be modulators of MAGL and/or ABHD6 and their use as medicinal agents, processes for their preparation, and pharmaceutical compositions that include disclosed compounds as at least one active agent. The disclosure also provides for method of treating a patient in need thereof, where the patient is suffering from post-traumatic stress disorder comprising administering a disclosed compound or composition.